Measuring inconsistency in meta-analyses
Reads0
Chats0
TLDR
A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.Abstract:
Cochrane Reviews have recently started including the quantity I 2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice?
Systematic reviews and meta-analyses can provide convincing and reliable evidence relevant to many aspects of medicine and health care.1 Their value is especially clear when the results of the studies they include show clinically important effects of similar magnitude. However, the conclusions are less clear when the included studies have differing results. In an attempt to establish whether studies are consistent, reports of meta-analyses commonly present a statistical test of heterogeneity. The test seeks to determine whether there are genuine differences underlying the results of the studies (heterogeneity), or whether the variation in findings is compatible with chance alone (homogeneity). However, the test is susceptible to the number of trials included in the meta-analysis. We have developed a new quantity, I 2, which we believe gives a better measure of the consistency between trials in a meta-analysis.
Assessment of the consistency of effects across studies is an essential part of meta-analysis. Unless we know how consistent the results of studies are, we cannot determine the generalisability of the findings of the meta-analysis. Indeed, several hierarchical systems for grading evidence state that the results of studies must be consistent or homogeneous to obtain the highest grading.2–4
Tests for heterogeneity are commonly used to decide on methods for combining studies and for concluding consistency or inconsistency of findings.5 6 But what does the test achieve in practice, and how should the resulting P values be interpreted?
A test for heterogeneity examines the null hypothesis that all studies are evaluating the same effect. The usual test statistic …read more
Citations
More filters
Journal ArticleDOI
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
John Danesh,Stephen Kaptoge,Andrea G Mann,Nadeem Sarwar,Angela M. Wood,Sara B Angleman,Frances Wensley,Julian P T Higgins,Lucy T. Lennon,Gudny Eiriksdottir,Ann Rumley,Peter H. Whincup,Gordon D.O. Lowe,Vilmundur Gudnason +13 more
TL;DR: Long-term IL-6 levels are associated with CHD risk about as strongly as are some major established risk factors, but causality remains uncertain, highlighting the potential relevance of IL- 6–mediated pathways to CHD.
Journal ArticleDOI
Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments
Anne-Marie H Krebber,Laurien M. Buffart,Gitta Kleijn,I. Riepma,R. de Bree,Charles R. Leemans,Annemarie Becker,Johannes Brug,A. van Straten,Pim Cuijpers,I.M. Verdonck-de Leeuw,I.M. Verdonck-de Leeuw +11 more
TL;DR: The prevalence of depression in cancer patients assessed by diagnostic interviews and self‐report instruments and to study differences in prevalence between type of instrument, type of cancer and treatment phase are investigated.
Journal ArticleDOI
Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
TL;DR: A systematic review and meta-analysis of the effects of ARBs on urinary protein excretion in patients with nephropathy compared with placebo and other antihypertensive agents and their combinations showed that ARBs delay progression of proteinuria over the short (1 to 4 months) and longer (5 to 12 months) terms.
Journal ArticleDOI
Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.
TL;DR: Pooled prevalence of CIC in the community was 14%, and of similar magnitude in most geographical regions, and rates were higher in women, older individuals, and those of lower socioeconomic status.
Journal ArticleDOI
Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants
TL;DR: A range of sensitivity analyses are discussed that will either support or question the validity of causal inference from a Mendelian randomization analysis with multiple genetic variants, and those that can be undertaken using summarized data are focused on.
References
More filters
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal ArticleDOI
The combination of estimates from different experiments.
TL;DR: The problem of making a combined estimate has been discussed previously by Cochran and Yates and Cochran (1937) for agricultural experiments, and by Bliss (1952) for bioassays in different laboratories as discussed by the authors.
Journal ArticleDOI
Tamoxifen for early breast cancer: An overview of the randomised trials
TL;DR: The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
Journal Article
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
TL;DR: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented in this paper, which approximately doubles the amount of evidence from trials of about 5 years of tamoxifier and, taking all trials together, on events occurring more than 5 years after randomisation.
Journal ArticleDOI
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.
TL;DR: In this paper, the authors evaluated standard error, precision (inverse of standard error), variance, inverse of variance, sample size and log sample size (vertical axis) and log odds ratio, log risk ratio and risk difference (horizontal axis).